| |
| |
|
| Insider
Information: |
Vaishnaw Akshay |
| Relationship: |
President |
| City: |
Cambridge |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
22,774 |
|
|
Indirect Shares
|
515 |
|
|
| Direct
Value |
$3,415,189 |
|
|
|
Indirect Value
|
$77,229 |
|
|
| Total
Shares |
23,289 |
|
|
| Total
Value |
$3,492,418 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
2
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
2
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
-2.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -26.9%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Alnylam Pharmaceuticals Inc |
ALNY |
President |
2023-08-04 |
22,774 |
2023-08-04 |
515 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ALNY |
Alnylam Pharmaceuticals I... |
President |
• – – |
2023-08-04 |
4 |
S |
$184.70 |
$753,986 |
D/D |
(4,057) |
22,774 |
0 |
% |
|
| ALNY |
Alnylam Pharmaceuticals I... |
President |
• – – |
2023-08-03 |
4 |
A |
$0.00 |
$0 |
D/D |
8,941 |
26,831 |
0 |
- |
|
| ALNY |
Alnylam Pharmaceuticals I... |
President |
• – – |
2023-04-27 |
4 |
S |
$193.18 |
$465,464 |
D/D |
(2,392) |
17,890 |
0 |
% |
|
| ALNY |
Alnylam Pharmaceuticals I... |
President |
• – – |
2023-04-26 |
4 |
A |
$0.00 |
$0 |
D/D |
5,312 |
20,282 |
0 |
- |
|
| ALNY |
Alnylam Pharmaceuticals I... |
President |
• – – |
2023-02-10 |
4 |
AS |
$213.13 |
$8,216,324 |
D/D |
(38,044) |
14,970 |
0 |
% |
|
| ALNY |
Alnylam Pharmaceuticals I... |
President |
• – – |
2023-02-10 |
4 |
OE |
$63.00 |
$1,947,519 |
D/D |
30,913 |
53,014 |
0 |
- |
|
| ALNY |
Alnylam Pharmaceuticals I... |
President |
• – – |
2022-12-05 |
4 |
D |
$226.20 |
$299,489 |
D/D |
(1,324) |
22,101 |
0 |
- |
|
| ALNY |
Alnylam Pharmaceuticals I... |
President |
• – – |
2022-12-05 |
4 |
OE |
$42.22 |
$299,938 |
D/D |
5,079 |
23,425 |
0 |
- |
|
| ALNY |
Alnylam Pharmaceuticals I... |
President |
• – – |
2022-08-04 |
4 |
D |
$189.76 |
$1,160,335 |
D/D |
(6,052) |
18,346 |
0 |
- |
|
| ALNY |
Alnylam Pharmaceuticals I... |
President |
• – – |
2022-08-03 |
4 |
A |
$0.00 |
$0 |
D/D |
13,183 |
24,398 |
0 |
- |
|
| ALNY |
Alnylam Pharmaceuticals I... |
President, R&D |
• – – |
2021-12-23 |
4 |
AS |
$186.22 |
$549,698 |
D/D |
(2,879) |
11,215 |
0 |
% |
|
| ALNY |
Alnylam Pharmaceuticals I... |
President, R&D |
• – – |
2021-12-22 |
4 |
D |
$186.48 |
$479,690 |
D/D |
(2,538) |
14,094 |
0 |
- |
|
| ALNY |
Alnylam Pharmaceuticals I... |
President, R&D |
• – – |
2021-12-21 |
4 |
A |
$0.00 |
$0 |
D/D |
5,417 |
16,632 |
0 |
- |
|
| ALNY |
Alnylam Pharmaceuticals I... |
President, R&D |
• – – |
2021-08-09 |
4 |
OE |
$63.00 |
$682,542 |
D/D |
10,834 |
22,049 |
0 |
- |
|
| ALNY |
Alnylam Pharmaceuticals I... |
President, R&D |
• – – |
2021-08-09 |
4 |
AS |
$200.00 |
$2,166,800 |
D/D |
(10,834) |
11,215 |
0 |
% |
|
| ALNY |
Alnylam Pharmaceuticals I... |
President, R&D |
• – – |
2021-06-18 |
4 |
AS |
$175.00 |
$2,573,900 |
D/D |
(14,708) |
11,215 |
0 |
% |
|
| ALNY |
Alnylam Pharmaceuticals I... |
President, R&D |
• – – |
2021-06-18 |
4 |
OE |
$42.22 |
$723,495 |
D/D |
11,804 |
25,923 |
0 |
- |
|
| ALNY |
Alnylam Pharmaceuticals I... |
President, R&D |
• – – |
2021-04-21 |
4 |
AS |
$135.41 |
$374,135 |
D/D |
(2,732) |
14,119 |
0 |
% |
|
| ALNY |
Alnylam Pharmaceuticals I... |
President, R&D |
• – – |
2021-04-20 |
4 |
D |
$131.75 |
$309,983 |
D/D |
(2,351) |
16,851 |
0 |
- |
|
| ALNY |
Alnylam Pharmaceuticals I... |
President, R&D |
• – – |
2021-04-19 |
4 |
AS |
$136.76 |
$510,192 |
D/D |
(3,706) |
19,202 |
0 |
% |
|
| ALNY |
Alnylam Pharmaceuticals I... |
President, R&D |
• – – |
2021-04-19 |
4 |
A |
$0.00 |
$0 |
D/D |
5,083 |
22,908 |
0 |
- |
|
| ALNY |
Alnylam Pharmaceuticals I... |
President, R&D |
• – – |
2021-02-12 |
4 |
D |
$152.53 |
$266,441 |
D/D |
(1,710) |
17,825 |
0 |
- |
|
| ALNY |
Alnylam Pharmaceuticals I... |
President, R&D |
• – – |
2021-02-11 |
4 |
A |
$0.00 |
$0 |
D/D |
5,416 |
19,535 |
0 |
- |
|
| ALNY |
Alnylam Pharmaceuticals I... |
President, R&D |
• – – |
2020-09-29 |
4 |
AS |
$140.00 |
$135,940 |
D/D |
(971) |
14,119 |
0 |
% |
|
| ALNY |
Alnylam Pharmaceuticals I... |
President, R&D |
• – – |
2020-09-29 |
4 |
OE |
$42.22 |
$40,996 |
D/D |
971 |
15,090 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
